A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-To-Severe Rheumatoid Arthritis

figure

posted on 2020-11-25, 20:02 authored by Christopher J. Edwards, Ruta Sawant, Vishvas Garg, Ella X. Du, Alan Friedman, Keith A. Betts

Article full text

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Keywords

Combination therapy Efficacy Matching adjusted indirect comparison Monotherapy Rheumatoid arthritis Tofacitinib Upadacitinib

Licence

CC BY-NC 4.0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM